Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
56,919,368
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
16,813,468
-
Shares change
-
+4,497,400
-
Total reported value, excl. options
-
$406,716,027
-
Value change
-
+$106,456,029
-
Number of buys
-
45
-
Number of sells
-
-32
-
Price
-
$24.19
Significant Holders of GLAUKOS Corp - Common Stock (GKOS) as of Q3 2015
84 filings reported holding GKOS - GLAUKOS Corp - Common Stock as of Q3 2015.
GLAUKOS Corp - Common Stock (GKOS) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,813,468 shares
of 56,919,368 outstanding shares and own 29.54% of the company stock.
Largest 10 shareholders include Versant Venture Management, LLC (3,142,217 shares), Meritech Capital Associates III L.L.C. (3,026,678 shares), ORBIMED ADVISORS LLC (2,897,937 shares), FMR LLC (1,239,500 shares), GILDER GAGNON HOWE & CO LLC (1,048,285 shares), ALLIANCEBERNSTEIN L.P. (672,399 shares), WELLS FARGO & COMPANY/MN (661,166 shares), LORD, ABBETT & CO. LLC (626,377 shares), Capital World Investors (490,000 shares), and VANGUARD GROUP INC (427,426 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.